Talawar Tx, a biotech company developing potentially best-in-class bispecific antibodies that pair independent immunology and inflammatory (I&I) disease drivers, and JATT II Acquisition Corp (Nasdaq: ...

India’s Dr Reddy’s Laboratories (NYSE: RDY) has received a fresh Form 483 from the US Food and Drug Administration, keeping regulatory scrutiny fixed on one of its biologics manufacturing sites just ...

Lycia Therapeutics has raised $75 million in an oversubscribed series D financing to support clinical development of its extracellular protein degrader pipeline. The South San Francisco biotech said ...

India’s pharmaceutical industry is witnessing a surge in global partnerships, with countries such as Switzerland, Uzbekistan, ...

French drugmaker Ipsen (Euronext: IPN) today announced it has entered into a definitive merger agreement to acquire US cancer focused biotech Kartos Therapeutics. The acquisition adds navtemadlin, an ...

US pharma giant Merck & Co (NYSE: MRK), known as MSD outside of the USA and Canada, today announced an agreement with the ADAP Crisis Task Force (ACTF) to help state AIDS Drug Assistance Programs ...

A Versant Ventures-founded biotech using targeted gene modulation to build a foundational portfolio in rare monogenic ...

A Hong Kong–listed biotechnology company focused on the discovery, development and commercialization of small-molecule and peptide therapeutics. Ascletis Pharma develops medicines across metabolic ...

Syremis Therapeutics is based in Tel Aviv, Israel and Boston, Massachusetts. The company is building a neuropsychiatry-focused R&D organization with early clinical development activity centered in the ...

M&A was again a big feature in last week's news, with AbbVie’s acquisition of Apogee Therapeutics, along with its atopic ...

US biotech Viridian Therapeutics saw its shares climb more than 10% to $19.81 in after-hours activity Friday, when it ...

Swedish Orphan Biovitrum (STO: SOBI), also known as Sobi, said late Friday it had received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for its Biologics License ...